Endometrial Cancer Tissue Array of 150 Tissue Samples |
| Home >> Welcome to Pantomics Price List Download |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
Dedicated facility |
Catalog# EMC1501 - Human endometrial cancer tissue array
| Lot# | Cores | Size | Cut | Format | QA/QC | Price 1Slide |
Price Pack5 |
| EMC150101 | 150 | 1.1mm | 4um | 10X15 | H&E, IHC anti-Vimentin/Cytokeratin | $150 | $600 |
|
Order:
sales@pantomics.com
or call
1-415-863-2380,
Form:
Word
or
PDF;
PDF data |
|||||||
|
Recommended applications:
For Research use only. RNA or protein endometrium cancer/non-tumor tissue profiling using IHC or ISH;
Antibody characterization. Description: Endometrial cancer tissue array, 150 cores including 75 cases of uninvolved and neoplastic tissues of the endometrium in duplicates. All the tissues were from surgical resection. They were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or APES coated Superfrost slides. They all have a guaranteed six months' shelf-life at 4C from the date of shipment. Each slide has >95% tissue core retention. |
 |
|
Array |
Age |
Sex |
Anatomic |
Histology |
Grade |
Stage (TNM) |
Images |
|
A1,B1 |
52 |
F |
Endometrium |
Normal |
|
|
|
|
A2,B2 |
45 |
F |
Endometrium |
Normal |
|
|
|
|
A3,B3 |
31 |
F |
Endometrium |
Normal |
|
|
|
|
A4,B4 |
53 |
F |
Endometrium |
Atypical hyperplasia |
|
|
|
|
A5,B5 |
63 |
F |
Endometrium |
Atypical hyperplasia |
|
|
|
|
A6,B6 |
44 |
F |
Endometrium |
Adenocarcinoma |
II |
T1N0M0 |
|
|
A7,B7 |
62 |
F |
Endometrium |
Adenocarcinoma |
II |
T1N1M0 |
|
|
A8,B8 |
56 |
F |
Endometrium |
Adenosquamous carcinoma |
|
T1N0M0 |
|
|
A9,B9 |
56 |
F |
Endometrium |
Adenocarcinoma |
III |
T1N0M0 |
|
|
A10,B10 |
56 |
F |
Endometrium |
Adenocarcinoma |
I |
T1N0M0 |
|
|
A11,B11 |
53 |
F |
Endometrium |
Adenocarcinoma |
III |
T2N1M0 |
|
|
A12,B12 |
51 |
F |
Endometrium |
Adenocarcinoma |
III |
T3N1M0 |
|
|
A13,B13 |
51 |
F |
Endometrium |
Adenocarcinoma |
I~II |
T1N0M0 |
|
|
A14,B14 |
|
F |
Endometrium |
Adenocarcinoma |
III |
T1N0M0 |
|
|
A15,B15 |
43 |
F |
Endometrium |
Adenocarcinoma |
I |
T1N0M0 |
|
|
C1,D1 |
46 |
F |
Endometrium |
Adenocarcinoma |
III |
T3N0M0 |
|
|
C2,D2 |
78 |
F |
Endometrium |
Adenocarcinoma |
II |
T2N1M0 |
|
|
C3,D3 |
53 |
F |
Endometrium |
Adenocarcinoma |
I~II |
T1N0M0 |
|
|
C4,D4 |
49 |
F |
Endometrium |
Adenocarcinoma |
I |
T1N1M0 |
|
|
C5,D5 |
47 |
F |
Endometrium |
Squamous cell carcinoma |
I |
T1N0M0 |
|
|
C6,D6 |
|
F |
Endometrium |
Adenocarcinoma |
I~II |
T2N0M0 |
|
|
C7,D7 |
74 |
F |
Endometrium |
Adenocarcinoma |
III |
T2N0M0 |
|
|
C8,D8 |
51 |
F |
Endometrium |
Adenocarcinoma |
III |
T1N0M0 |
|
|
C9,D9 |
36 |
F |
Endometrium |
Adenocarcinoma |
III |
T1N0M0 |
|
|
C10,D10 |
48 |
F |
Endometrium |
Adenocarcinoma |
I~II |
T2N0M0 |
|
|
C11,D11 |
59 |
F |
Endometrium |
Adenocarcinoma |
I~II |
T1N0M0 |
|
|
C12,D12 |
43 |
F |
Endometrium |
Adenocarcinoma |
II~III |
T1N1M0 |
|
|
C13,D13 |
40 |
F |
Endometrium |
Adenocarcinoma |
I~II |
T2N1M0 |
|
|
C14,D14 |
70 |
F |
Endometrium |
Adenocarcinoma |
II~III |
T2N0M0 |
|
|
C15,D15 |
54 |
F |
Endometrium |
Adenocarcinoma |
II~III |
T1N0M0 |
|
|
E1,F1 |
48 |
F |
Endometrium |
Adenocarcinoma |
II |
T1N0M0 |
|
|
E2,F2 |
53 |
F |
Endometrium |
Adenocarcinoma |
I~II |
T1N0M0 |
|
|
E3,F3 |
63 |
F |
Endometrium |
Adenocarcinoma |
II |
T1N0M0 |
|
|
E4,F4 |
60 |
F |
Endometrium |
Adenocarcinoma |
I~II |
T1N0M0 |
|
|
E5,F5 |
41 |
F |
Endometrium |
Adenocarcinoma |
II |
T1N0M0 |
|
|
E6,F6 |
48 |
F |
Endometrium |
Adenocarcinoma |
I~II |
T2N0M0 |
|
|
E7,F7 |
70 |
F |
Endometrium |
Adenosquamous carcinoma |
III |
T1N0M0 |
|
|
E8,F8 |
68 |
F |
Endometrium |
Adenocarcinoma |
I~II |
T1N0M0 |
|
|
E9,F9 |
56 |
F |
Endometrium |
Adenosquamous carcinoma |
III |
T1N0M0 |
|
|
E10,F10 |
53 |
F |
Endometrium |
Adenocarcinoma |
II~III |
T1N0M0 |
|
|
E11,F11 |
53 |
F |
Endometrium |
Adenosquamous carcinoma |
III |
T1N0M0 |
|
|
E12,F12 |
60 |
F |
Endometrium |
Adenocarcinoma |
II |
T1N0M0 |
|
|
E13,F13 |
52 |
F |
Endometrium |
Adenocarcinoma |
II~III |
T1N0M0 |
|
|
E14,F14 |
41 |
F |
Endometrium |
Adenocarcinoma |
I~II |
T1N0M0 |
|
|
E15,F15 |
50 |
F |
Endometrium |
Adenocarcinoma |
III |
T1N0M0 |
|
|
G1,H1 |
55 |
F |
Endometrium |
Adenocarcinoma |
II |
T1N0M0 |
|
|
G2,H2 |
53 |
F |
Endometrium |
Undifferentiated carcinoma |
|
T1N0M0 |
|
|
G3,H3 |
50 |
F |
Endometrium |
Stromal sarcoma |
|
T1N0M0 |
|
|
G4,H4 |
60 |
F |
Endometrium |
Adenocarcinoma |
I~II |
T1N0M0 |
|
|
G5,H5 |
53 |
F |
Endometrium |
Adenocarcinoma |
I~II |
T1N0M0 |
|
|
G6,H6 |
49 |
F |
Endometrium |
Adenocarcinoma |
I~II |
T1N0M0 |
|
|
G7,H7 |
53 |
F |
Endometrium |
Adenocarcinoma |
II |
T2N0M0 |
|
|
G8,H8 |
54 |
F |
Endometrium |
Adenocarcinoma |
II |
T2N0M0 |
|
|
G9,H9 |
36 |
F |
Endometrium |
Undifferentiated carcinoma |
|
T2N0M0 |
|
|
G10,H10 |
53 |
F |
Endometrium |
Adenocarcinoma |
II |
T2N0M0 |
|
|
G11,H11 |
45 |
F |
Endometrium |
Adenocarcinoma |
I~II |
T2N0M0 |
|
|
G12,H12 |
51 |
F |
Endometrium |
Adenocarcinoma |
III |
T2N0M0 |
|
|
G13,H13 |
68 |
F |
Endometrium |
Adenocarcinoma |
II |
T2N0M0 |
|
|
G14,H14 |
39 |
F |
Endometrium |
Adenocarcinoma |
I |
T2N0M0 |
|
|
G15,H15 |
44 |
F |
Endometrium |
Stromal sarcoma |
|
|
|
|
I1,J1 |
46 |
F |
Endometrium |
Adenocarcinoma |
III |
T1N0M0 |
|
|
I2,J2 |
43 |
F |
Endometrium |
Adenocarcinoma |
II~III |
T2N0M0 |
|
|
I3,J3 |
53 |
F |
Endometrium |
Adenocarcinoma |
III |
T3N0M0 |
|
|
I4,J4 |
67 |
F |
Endometrium |
Adenocarcinoma |
III |
T2N0M0 |
|
|
I5,J5 |
51 |
F |
Endometrium |
Undifferentiated carcinoma |
|
T2N1M0 |
|
|
I6,J6 |
42 |
F |
Endometrium |
Adenocarcinoma |
II |
T1N0M0 |
|
|
I7,J7 |
52 |
F |
Endometrium |
Adenocarcinoma |
III |
T1N0M0 |
|
|
I8,J8 |
66 |
F |
Endometrium |
Undifferentiated carcinoma |
|
T2N0M0 |
|
|
I9,J9 |
60 |
F |
Endometrium |
Adenocarcinoma |
III |
T1N0M0 |
|
|
I10,J10 |
54 |
F |
Endometrium |
Adenocarcinoma |
II |
T1N0M0 |
|
|
I11,J11 |
33 |
F |
Endometrium |
Adenocarcinoma |
I~II |
T1N0M0 |
|
|
I12,J12 |
60 |
F |
Endometrium |
Adenocarcinoma |
I~II |
T1N0M0 |
|
|
I13,J13 |
58 |
F |
Endometrium |
Squamous cell carcinoma |
II~III |
T1N0M0 |
|
|
I14,J14 |
43 |
F |
Endometrium |
Adenocarcinoma |
II |
T1N0M0 |
|
|
I15,J15 |
40 |
F |
Endometrium |
Adenocarcinoma |
II |
T2N0M0 |
|
-------------------------------------------------------------------------------------------------
All Products
|
Ordering Information
|
Privacy Policy
Copyright © 2004-2005,
Pantomics, Inc.
457 Mariposa Street, San Francisco, CA
94107, USA.
Tel: 415-863-2380